Global expansion Wandercraft is actively partnering with rehabilitation providers, healthcare facilities, and mobility specialists across the US and Europe, signaling strong sales opportunities for personal exoskeletons like Eve and healthcare-focused deployments such as Atalante in hospitals and clinics.

Strategic partnerships Recent collaborations with National Seating & Mobility, US VetServ, and Good Shepherd Rehabilitation indicate a growing ecosystem for access, financing, and integration of exoskeletons into complex care and veteran programs, presenting co-selling and channel opportunities.

Industrial momentum Calvin-40 industrial humanoid robot targets hazardous or heavy-demand tasks, with existing deployments including Renault, suggesting cross-sell potential to manufacturing and logistics customers seeking automation with safety and ergonomic benefits.

Financing readiness A substantial funding base and revenue trajectory, plus board-level expertise from Permobil leadership, imply readiness to support large-scale deployments and multi-site contracts with favorable financing and sustainability-backed ROI for customers.

Clinical and home use Eve is advancing through U.S. clinical trials with a planned 2026 launch, while Atalante demonstrates hospital-based mobility solutions; opportunities exist in payer engagement, clinical adoption pathways, and home-use pilots for personal exoskeletons.